We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NOMD:NYSENomad Foods Limited Analysis

Data as of 2026-04-20 - not real-time

$9.67

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nomad Foods trades around $9.67, comfortably above its DCF-derived fair value of roughly $2.73, suggesting a significant premium. The stock sits beneath its 20‑day (≈9.70), 50‑day (≈10.69) and 200‑day (≈12.88) moving averages, with a 30‑day volatility of over 31% and a very low beta (~0.07), indicating high price swings but limited market‑wide correlation. Fundamentals show a modest 2.6% revenue contraction, thin profit margins (~4.5%) and a generous dividend yield of nearly 7% supported by a payout ratio of 66%, though free cash flow remains limited.
Management’s 2026 strategic plan emphasizes agility, cost efficiency and an aggressive share‑repurchase programme, while recent earnings beat expectations but missed revenue guidance, triggering a 6% price drop. The bearish technical backdrop, decreasing volume and a modestly bullish MACD histogram contrast with the high dividend appeal and undervalued book metrics, leaving investors weighing short‑term price weakness against long‑term value and income potential.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major moving averages indicating bearish momentum
  • Decreasing volume and recent 6% drop after earnings miss
  • Premium valuation relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • High dividend yield with a payout ratio below 70%
  • Management’s share‑repurchase commitment supporting price support
  • Revenue decline and margin pressure tempering upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong book value (P/B ~0.47) indicating deep value cushion
  • Consumer‑defensive sector offering resilience in downturns
  • Strategic focus on efficiency and agility that could stabilize earnings

Key Metrics & Analysis

Financial Health

Revenue Growth-2.60%
Profit Margin4.51%
P/E Ratio9.0
ROE5.30%
ROA4.01%
Debt/Equity91.77
P/B Ratio0.5
Op. Cash Flow$330.7M
Free Cash Flow$175.6M

Technical Analysis

TrendBearish
RSI41.0
Support$9.43
Resistance$10.02
MA 20$9.70
MA 50$10.69
MA 200$12.88
MACDBullish
VolumeDecreasing
Fear & Greed Index87.32

Valuation

Fair Value$2.73
GradeOvervalued
TypeValue
Dividend Yield6.98%

Risk Assessment

Beta0.07
Volatility31.79%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.